Stichting Hemato-oncologie Voor Volwassenen Nederland

This study is testing if adding a new drug called bleximenib to standard chemotherapy works better than chemotherapy alone for adults newly diagnosed with specific genetic types of acute myeloid leukemia (AML). About 875 participants will receive standard chemo plus either blexim…